Usnic acid

2,6-Diacetyl-3,7,9-trihydroxy-8,9b-dimethyldibenzofuran-1-one

C18H16O7 (344.0896)


A member of the class of dibenzofurans that is dibenzo[b,d]furan-1(9bH)-one substituted by acetyl groups at positions 2 and 6, hydroxy groups at positions 3 and 7 and methyl groups at positions 8 and 9b. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 1.457 D000890 - Anti-Infective Agents > D000935 - Antifungal Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 1.456 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.458 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.459 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.455 (+)-Usnic acid is isolated from isolated from lichens, binds at the ATP-binding pocket of mTOR, and inhibits mTORC1/2 activity. (+)-Usnic acid inhibits the phosphorylation of mTOR downstream effectors: Akt (Ser473), 4EBP1, S6K, induces autophay, with anti-cancer activity[1]. (+)-Usnic acid possesses antimicrobial activity against a number of planktonic gram-positive bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium[2]. (+)-Usnic acid is isolated from isolated from lichens, binds at the ATP-binding pocket of mTOR, and inhibits mTORC1/2 activity. (+)-Usnic acid inhibits the phosphorylation of mTOR downstream effectors: Akt (Ser473), 4EBP1, S6K, induces autophay, with anti-cancer activity[1]. (+)-Usnic acid possesses antimicrobial activity against a number of planktonic gram-positive bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium[2]. (+)-Usnic acid is isolated from isolated from lichens, binds at the ATP-binding pocket of mTOR, and inhibits mTORC1/2 activity. (+)-Usnic acid inhibits the phosphorylation of mTOR downstream effectors: Akt (Ser473), 4EBP1, S6K, induces autophay, with anti-cancer activity[1]. (+)-Usnic acid possesses antimicrobial activity against a number of planktonic gram-positive bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium[2]. (+)-Usnic acid is isolated from isolated from lichens, binds at the ATP-binding pocket of mTOR, and inhibits mTORC1/2 activity. (+)-Usnic acid inhibits the phosphorylation of mTOR downstream effectors: Akt (Ser473), 4EBP1, S6K, induces autophay, with anti-cancer activity[1]. (+)-Usnic acid possesses antimicrobial activity against a number of planktonic gram-positive bacteria, including Staphylococcus aureus, Enterococcus faecalis, and Enterococcus faecium[2]. Usnic acid, a lichen-derived secondary metabolite, has a unique dibenzofuran skeleton. Usnic acid has excellent anticancer and antimicrobial properties. Usnic acid significantly inhibits RANKL-mediated osteoclast formation and function by reducing the transcriptional and translational expression of NFATc1[1]. Usnic acid, a lichen-derived secondary metabolite, has a unique dibenzofuran skeleton. Usnic acid has excellent anticancer and antimicrobial properties. Usnic acid significantly inhibits RANKL-mediated osteoclast formation and function by reducing the transcriptional and translational expression of NFATc1[1].

   

4-methylidene-5-oxo-2-undecyloxolane-3-carboxylic acid

4-methylidene-5-oxo-2-undecyloxolane-3-carboxylic acid

C17H28O4 (296.1987)


   

(+)-Usnic acid

(+)-Usnic acid

C18H16O7 (344.0896)


   

Roccellaric acid

(2R,3S,4S)-4-methyl-5-oxo-2-tridecyloxolane-3-carboxylic acid

C19H34O4 (326.2457)


   

(2S,3S)-4-methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid

(2S,3S)-4-methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid

C19H32O4 (324.23)


   

4-methyl-5-oxo-2-undecyloxolane-3-carboxylic acid

4-methyl-5-oxo-2-undecyloxolane-3-carboxylic acid

C17H30O4 (298.2144)


   

(2s)-4-methyl-5-oxo-2-tridecyl-2h-furan-3-carboxylic acid

(2s)-4-methyl-5-oxo-2-tridecyl-2h-furan-3-carboxylic acid

C19H32O4 (324.23)


   

(2r,3s,4s)-4-methyl-5-oxo-2-undecyloxolane-3-carboxylic acid

(2r,3s,4s)-4-methyl-5-oxo-2-undecyloxolane-3-carboxylic acid

C17H30O4 (298.2144)


   

4-methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid

4-methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid

C19H32O4 (324.23)


   

4-methyl-5-oxo-2-tridecyloxolane-3-carboxylic acid

4-methyl-5-oxo-2-tridecyloxolane-3-carboxylic acid

C19H34O4 (326.2457)


   

(2s,3s,4s)-4-methyl-5-oxo-2-tridecyloxolane-3-carboxylic acid

(2s,3s,4s)-4-methyl-5-oxo-2-tridecyloxolane-3-carboxylic acid

C19H34O4 (326.2457)


   

(2s,3r)-4-methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid

(2s,3r)-4-methylidene-5-oxo-2-tridecyloxolane-3-carboxylic acid

C19H32O4 (324.23)


   

(2r,3s,4s)-4-methyl-5-oxo-2-tridecyloxolane-3-carboxylic acid

(2r,3s,4s)-4-methyl-5-oxo-2-tridecyloxolane-3-carboxylic acid

C19H34O4 (326.2457)


   

(2r,3s)-4-methylidene-5-oxo-2-undecyloxolane-3-carboxylic acid

(2r,3s)-4-methylidene-5-oxo-2-undecyloxolane-3-carboxylic acid

C17H28O4 (296.1987)